|
The files are password protected for members. Please contact us if you forgot your username and password or for new members, to obtain one. Click on the highlighted/colored portion to open. Some of these are large files and may take a some time to download and open. They should open in Adobe Acrobat Reader. You will need Adobe Acrobat Reader (free download from Adobe). If the file does not appear, or adobe opens but you get a blank screen, (primarily for Acrobat 5.0 Reader users in Internet Explorer 6.0 and NT or XP systems), you will need to open Acrobat Reader, and select preferences in the Edit menu. Click options and uncheck the open in browser box if checked. This should fix the problem and Adobe files will open in a new window. Clicking the back button when finished viewing the file will return you to the summaries page if it opened in the browser. If opened in a new window, simply close the window to return to the SFAI summaries page.
March 30, 2005
Estrogen receptor analysis of breast cancer: Is quantiative better?: Dr. Allen Gown
Application of Silver Based Chromogenic In-situ Hybridization (SISH) and IHC to Surgical Pathology Diagnosis (2 parts): Drs. Thomas Grogan and Richard N. Eisen
FISH Analysis of Tumors With Quantitative Methods: Dr. Allen Gown
October 4, 2003
Neurodegenerative diseaeses and IHC: Dr. Mark Edgar
CNS Tumors and IHC: Dr. Mark Edgar
Identification and Treatment of Prion Diseases: Dr. Richard Kascsak
Alzheimer's Disease: Therapeutic Strategies: Dr. Thomas Wisniewski
Comparative Veterinary Oncology and Pathology: Dr. Philip Bergman
Emerging Infectious Diseaes and IHC: Dr. Sherif Zaki
May 21, 2003
P16 IHC in Cervical Smears and Surgical Material: Dr. William J. Klump
CDX2: A New Marker of Intestinal Differentiation: Drs. Richard W. Cartun and Richard N. Eisen
CK 7 Positive, CK20 Negative Colon Carcinomas: Dr. Neal Goldstein
Synthetic peptides as novel quality control for quantitative IHC: Dr. Steven Bogen: coming soon
October 26, 2002
Bioinformatics and Breast Cancer: Dr. Federico Monzon
The ErbB Family: Therapeutic Target and Diagnostic Dilemma: Albert J. Kovatich, MS
Biomarkers in DCIS: Dr. Juan Palazzo
Optimal Fixation Times for ER Analysis: Dr. Neal Goldstein
Phosphorylated Her-2/neu and EGFR as prognostic factors in breast cancer: Dr. Michael DiGiovanna
July 17, 2002
Pulmonary Neoplasia and Mesothelioma Update: Dr. Douglas Flieder
May 22, 2001
MUC proteins and neoplasia: Dr. Volkan Adsay
P504S: A novel marker of prostate cancer: Dr. Zhong Jiang
P63: Immunohistochemical applications: Dr. Allen Gown
Sept. 8, 2001
Dr. Mark Wick:
Prognostic and Predictive Tests in Anatomic Pathology
Immunohistology in Neoplastic Dermatopathology
Diagnostic Immunohistology in Selected Urologic Neoplasms
Diagnostic Immunohistology in Urologic Path
Dr. Rodney Miller:
Technical Immunohistochemistry
Meeting: January 17, 2001
Case Presentation: Dr. James Weisberger
Gynecologic Pathology and IPOX update: Dr. Robert Soslow
WT1 antibody and diagnostic pathology: Dr. Allen Gown
Meeting: November 4, 2000
Prognostic Markers in Colorectal Cancer: Juan Palazzo, M.D.
Hereditary Non-Polyposis Colorectal Carcinoma: Dr. Tina Bocker Edmonston
The Use of Cytokeratins in GE Junction Pathology: Dr. Robert Odze, M.D.
Immunohistochemistry of Pancreaticobiliary Adenocarcinomas: Neal Goldstein, M.D.
Liver from Bone Marrow in Humans: Dr. Neil Theise
1-Canals of Hering and Stem Cells
2-Liver from mouse bone marrow
3-Liver from human bone marrow
Meeting: July 26, 2000
The Workup of Renal Biopsies: Dr. Vivette D'Agati
Meeting: April 19, 2000
Case Presentations: Metastases to the GI Tract : Dr. Federico Monzon
A Holistic Approach to Antigen Retrieval: David Tacha, HT/HTL (ASCP)
Chemokines in Hodgkin's Disease: Dr. Julie Teruya-Feldstein
|